tiprankstipranks
Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)
PremiumThe FlyLyra Therapeutics reports Q2 EPS (74c), consensus (33c)
5M ago
Lyra Therapeutics trading resumes
Premium
The Fly
Lyra Therapeutics trading resumes
8M ago
Lyra implements layoff of 75% of workforce, to evaluate strategic options
Premium
The Fly
Lyra implements layoff of 75% of workforce, to evaluate strategic options
8M ago
Lyra Therapeutics downgraded to Underperform from Buy at BofA
PremiumThe FlyLyra Therapeutics downgraded to Underperform from Buy at BofA
9M ago
Lyra Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Lyra Therapeutics downgraded to Hold from Buy at Jefferies
9M ago
Lyra Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Lyra Therapeutics downgraded to Neutral from Buy at BTIG
9M ago
Lyra Therapeutics Announces Board and Committee Changes
PremiumCompany AnnouncementsLyra Therapeutics Announces Board and Committee Changes
9M ago
Lyra Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lyra Therapeutics management to meet with Cantor Fitzgerald
9M ago
Lyra Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lyra Therapeutics management to meet with Cantor Fitzgerald
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100